HIV Therapy Effective in Reducing Virus in Multi-Drug Resistant Patients – APhA submits compounding comments to FDA.

4Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

HIV Therapy Effective in Reducing Virus in Multi-Drug Resistant Patients – APhA submits compounding comments to FDA. – (866) 348-2889.

A new HIV therapy demonstrated its efficacy in reducing the virus and boosting immunity in drug-resistant patients, according to a new study published in the New England Journal of Medicine.

The phase 3 trial evaluated the newly-approved treatment, ibalizumab, in 40 patients with advanced, multi-drug-resistant (MDR) HIV infection. A novel therapy, ibalizumab, works by targeting the primary receptor for HIV entry into immune cells, known as CD4 T cells.

For the study, the patients received an intravenous dose of ibalizumab in addition to their failing regimen for 1 week. Then, they received ibalizumab in combination with optimized treatment regimens for 6 months.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

USPSTF Updates Guidelines for Cervical Cancer Screening – Drug for nerve pain boosts high for opioid abusers.

7Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

USPSTF Updates Guidelines for Cervical Cancer Screening – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

What type of cervical cancer screening should a woman get, if any, and how often? The latest recommendation from the United States Preventive Services Task Force (USPSTF) said Tuesday that it depends on a woman’s age and other factors, but those 30 or older have a new option.

The number of deaths from cervical cancer in the United States has decreased since widespread cervical cancer screening began, falling to 2.3 from 2.8 deaths per 100,000 women. Still, 4170 will die from the disease this year, according to the American Cancer Society. Most will not have been adequately screened previously.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Study: Older Adults, Hispanics Less Likely to Receive HIV Testing – APhA submits compounding comments to FDA.

7Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Study: Older Adults, Hispanics Less Likely to Receive HIV Testing – APhA submits compounding comments to FDA. – (866) 348-2889.

Health care providers recommend routine HIV testing to individuals who are at risk of contracting the virus. However, misperceptions about HIV testing and risk remain a barrier to uptake in certain populations.

A recent study published in Medicine aimed to determine how age and ethnicity influence HIV testing. According to the findings, older adults and Hispanics are less likely to receive HIV testing, indicating an urgent need for improved interventions.

For the study, the researchers examined data on self-reported HIV risk and willingness to be tested. Using the 2014 Get Tested Coachella Valley Community Survey, the team collected data from nearly 1000 participants related to demographics, sexual history, HIV testing history, thoughts on who should get tested, and future preferences for HIV testing. Approximately 24% of adults living with HIV in Coachella Valley are 60 years or older.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Approves New Drug for Treatment of Seizures Associated With Dravet Syndrome – Drug for nerve pain boosts high for opioid abusers.

29960_pharmacyboard_standard_081816Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

FDA Approves New Drug for Treatment of Seizures Associated With Dravet Syndrome – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Officials with the FDA approved have approved stiripentol (Diacomit) for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.1 Stiripentol is indicated for use in patients 2 years of age and older who are taking clobazam.1 There are no clinical data to support the use of stiripentol as monotherapy in Dravet syndrome, according to the FDA.

Dravet syndrome is a rare genetic condition that usually appears during the first year of life with prolonged fever-related seizures. Other types of seizures typically appear later, including myoclonic seizures. Additionally, status epilepticus, a potentially life-threatening state of continuous seizure activity requiring emergency medical care, may occur. Children with Dravet syndrome typically experience poor development of language and motor skills, hyperactivity, and difficulty relating to others.1

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Expert Panel: Opioid Prescribing Limits Should be Based on Operation Performed – APhA submits compounding comments to FDA.

16321_pharmacyboard_standard_080416Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Expert Panel: Opioid Prescribing Limits Should be Based on Operation Performed – APhA submits compounding comments to FDA. – (866) 348-2889.

An expert panel of health care providers and patients are recommending that opioid prescribing limits should be based on the operation performed rather than a blanket approach. The ranges offered for each of 20 common operations generally call for reductions from the current rates of opioid prescription, and the researchers note that patients themselves favor using less of the medications than often prescribed.

In a recently published paper, the researchers, from Johns Hopkins University School of Medicine, explain the process of consensus reached by 30 surgeons, pain specialists, outpatient surgical nurse practitioners, surgical residents, patients and pharmacists.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Permits Marketing of Stimulation Device for Treatment of Obsessive Compulsive Disorder – Drug for nerve pain boosts high for opioid abusers.

16511-pharmacy-board-standard-041216Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

FDA Permits Marketing of Stimulation Device for Treatment of Obsessive Compulsive Disorder – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Officials with the FDA have given approval for marketing Brainsway’s Deep Transcranial Magnetic Stimulation (TMS) System. The device is utulized for treatment of obsessive compulsive disorder (OCD).

“Transcranial magnetic stimulation has shown its potential to help patients suffering from depression and headaches,” said Carlos Peña, PhD, MS, director of the Division of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health, in a prepared statement. “Patients with OCD who have not responded to traditional treatments now have another option.”

TMS is a procedure that utilizes magnetic fields to stimulate nerve cells in the brain. The FDA permitted marketing of TMS as a treatment for major depression in 2008, and the agency expanded the use to include TMS for treating pain associated with certain migraine headaches in 2013.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Stroke in Infant Linked to Siblings’ Preventable Virus – APhA submits compounding comments to FDA.

26799_graphic_standard_080816Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Stroke in Infant Linked to Siblings’ Preventable Virus – APhA submits compounding comments to FDA. – (866) 348-2889.

The varicella zoster virus (VZV), more commonly known as chickenpox, is notorious for covering the body in itchy red bumps and being highly contagious, particularly among children. Although rare today, due to vaccination, chickenpox has the potential to do much more damage than parents may think if children are exposed.1

Vaccination is crucial in preventing children from getting chickenpox and suffering from related complications, and for protecting children who cannot be vaccinated from becoming infected. Recently, an infant aged 11 months suffered a stroke 2 to 3 months after being infected with the varicella zoster virus, which was likely passed from older, unvaccinated siblings who developed chickenpox around the same time. The event emphasizes the importance in vaccinating children, according to a report published by Journal of Pediatrics.1

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

First Generic Epinephrine Auto-Injector Approved by FDA – Drug for nerve pain boosts high for opioid abusers.

14774_PHARMACY BOARD_072216Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

First Generic Epinephrine Auto-Injector Approved by FDA – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

The FDA has approved the first generic epinephrine auto-injector for the emergency treatment of allergic reactions, including anaphylaxis. Teva Pharmaceuticals’ approved product, 0.3 mg and 0.15 mg strengths generic versions of EpiPen and EpiPen Jr, is indicated for adults and pediatric patients who weigh more than 33 pounds.

“Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our longstanding commitment to advance access to lower cost, safe, and effective generic alternatives once patents and other exclusivities no longer prevent approval,” said FDA Commissioner Scott Gottlieb, MD, in a statement. “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Medicaid Expansion Boosts Health Coverage Among Low-Income Patients With Substance Use Disorders – APhA submits compounding comments to FDA.

16513-PHARMACY BOARD-standard-041216Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Medicaid Expansion Boosts Health Coverage Among Low-Income Patients With Substance Use Disorders – APhA submits compounding comments to FDA. – (866) 348-2889.

States that chose to expand Medicaid eligibility under the Affordable Care Act (ACA) have seen a greater decrease in uninsured rates among low-income patients with substance use disorders than states that did not expand Medicaid, according to the results of a recent study.

Following the 2014 ACA-mandated Medicaid expansion, 26 states and the District of Columbia allowed individuals with household incomes up to 138% of the federal poverty level to be eligible for health coverage under Medicaid. To assess the effect of this expansion on patients with substance use disorders, researchers from the Columbia University Mailman School of Public Health, and Columbia University Irving Medical Center analyzed 2008-2015 data from the National Survey on Drug Use and Health, focusing on Medicaid coverage among patients who had abused alcohol, cannabis, heroin, or cocaine.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Mayo Clinic Ranked Nation’s Best Hospital by U.S. News & World Report – Drug for nerve pain boosts high for opioid abusers.

14738_graphic_standard_070616Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Mayo Clinic Ranked Nation’s Best Hospital by U.S. News & World Report – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

The Mayo Clinic, Minnesota earned the top spot on US News & World Report’s rank of Best Hospitals for the third consecutive year, and was among the Top 5 in selected specialties. The 29th annual list is compiled to assist patients and their doctors in making informed decisions about where to receive care, according to the magazine.

In compiling is rankings, US News & World Report had compared more than 4,500 medical centers nationwide across 25 specialties, procedures, and conditions. Following the Mayo Clinic, the Cleveland Clinic placed second on the overall Best Hospitals list, and Johns Hopkins Hospital, Baltimore is ranked third in the nation. Massachusetts General Hospital, Boston and the University of Michigan Hospitals-Michigan Medicine, Ann Arbor, placed fourth and fifth, respectively, rounding out the top five.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off